Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VYALEV safely and effectively. See full prescribing information for VYALEV. VYALEV™ (foscarbidopa and foslevodopa) injection, for subcutaneous use Initial U.S. Approval: 1975
Medication labelWhy this: Advisory · dailymed-prescription
VYALEV is indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD).
- generic_name
- foscarbidopa/foslevodopa
- product_names
- foscarbidopa/foslevodopa
- ndc
- 0074-0501, 0074-0501-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en